Logo

DxTerity Diagnostics IFN-1 Test

Jun 09, 2022

DxTerity Diagnostics has launched its IFN-1 Test to help guide treatment of patients with systemic lupus erythematosus. The test measures Type-1 Interferon (IFN-1), a biomarker that indicates SLE disease severity and prognosis by measuring the expression levels of four genes associated with IFN-1 activity. By identifying patients as IFN-1 high or low, healthcare providers can make more informed treatment decisions. Los Angeles-based DxTerity noted the recent approval by the US Food and Drug Administration of AstraZeneca's Saphnelo (anifrolumab), a Type-1 Interferon receptor blocker that gives rheumatologist a new treatment option to mange lupus.

Breaking News
The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.